Director/PDMR Shareholding

By

Regulatory News | 11 Dec, 2018

Updated : 09:13

RNS Number : 0956K
Consort Medical PLC
11 December 2018
 

Consort Medical plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Consort Medical plc ("the Company") confirms that the Trustee of the Consort Medical plc Share Incentive Plan (SIP) has notified the Company that on 7 December 2018 the following Executive Directors and Persons Discharging Managerial responsibility ("PDMR") purchased ordinary shares of 10p each in the Company under the SIP.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Jonathan Glenn

 

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Consort Medical plc

 

b)

 

LEI

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each



Identification code

GB0000946276



b)

 

Nature of the transaction

 

 

Acquisition of Partnership shares by the SIP Trustee pursuant to the Company Share Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£7.257

21

 


 

 

 

 

 

d)

 

Aggregated information



N/A

- Aggregated volume




- Price




e)

 

Date of the transaction

 

2018-12-07

f)

 

Place of the transaction

 

London Stock Exchange XLON

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Paul Hayes

2

 

Reason for the notification

 

a)

 

Position/status

 

CFO

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Consort Medical plc

b)

 

LEI

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each



Identification code

GB0000946276



b)

 

Nature of the transaction

 

 

Acquisition of Partnership shares by the SIP Trustee pursuant to the Company Share Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£7.257

20

 


 

 

 

 

 

d)

 

Aggregated information



N/A

- Aggregated volume




- Price




e)

 

Date of the transaction

 

2018-12-07

f)

 

Place of the transaction

 

London Stock Exchange XLON

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKFLBFVLFFFBB

Last news